Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation - Wikidata - awgldk - TriplyDB

Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation

Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation

http://www.wikidata.org/entity/Q33882805

about

Kinetic characterization and phosphoregulation of the Francisella tularensis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase)Extracellular vesicles from infected cells: potential for direct pathogenesis Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome Francisella tularensis 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase: kinetic characterization and phosphoregulation An initial characterization of the serum phosphoproteome.The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells.Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome.Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery Enabling individualized therapy through nanotechnology Elevating sampling.Synthesis and characterization of hydrogel particles containing Cibacron Blue F3G-A Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.Highly efficient human serum filtration with water-soluble nanoporous nanoparticles.The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease.Capture, enrichment, and mass spectrometric detection of low-molecular-weight biomarkers with nanoporous silicon microparticles.Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.The use of NanoTrap particles as a sample enrichment method to enhance the detection of Rift Valley Fever Virus Combination of hydrogel nanoparticles and proteomics to reveal secreted proteins associated with decidualization of human uterine stromal cells.Chemokine-Releasing Nanoparticles for Manipulation of Lymph Node Microenvironment Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers.Preparation of abiotic polymer nanoparticles for sequestration and neutralization of a target peptide toxin.The use of Nanotrap particles in the enhanced detection of Rift Valley fever virus nucleoprotein.Reverse-Phase Microarray Analysis Reveals Novel Targets in Lymph Nodes of Bacillus anthracis Spore-Challenged Mice.Biomarker discovery by novel sensors based on nanoproteomics approaches.Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.Current state of the art for enhancing urine biomarker discovery.Chemokine-Releasing Microparticles Improve Bacterial Clearance and Survival of Anthrax Spore-Challenged Mice.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.Serum biomarkers identification by mass spectrometry in high-mortality tumors.-Omics and cancer biomarkers: link to the biological truth or bear the consequences.Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

P2860

Q21562674-E15A3E33-EB22-441C-B072-CCA1008B9F9A Q26779430-41BF502E-AE3C-4EE8-8466-635C5F9B5E58 Q28391849-67AF57AC-671C-4A79-99DB-522DA81BA339 Q28474977-A3010E66-AB2A-43B1-A3A3-2BA284841083 Q28543378-4149E303-08AD-43CB-9EE7-4527343CCAAC Q28743804-EFF33D7E-8447-493B-BA47-AAD0110B0C49 Q30381604-94C73C4F-0081-4307-810E-84CD3D63E80E Q30413065-27BE0CB4-1428-40B4-AD21-FA1BFE3536ED Q30475719-38A79031-BA48-4EC0-B0DC-97AEC99EE04B Q33518743-04E6B345-1AB6-4732-ABE9-2EF1F94B9EB4 Q33605010-EBCCE706-78BE-4804-88B8-A9F5DF82CF03 Q33862871-C0140174-1E8D-4165-943D-324F3FA00820 Q33917755-08959A0C-13C0-4C34-A07F-775898CBAA6D Q33983800-D3B83A06-B128-4027-ADC6-3DDD7BFEC4E0 Q34146442-C908D9B0-DFB8-49EF-931D-D9E1ED2514FC Q34282008-3927ACEC-51AE-4EEB-8094-5B99F36C0EB5 Q34333925-739C1857-4C59-4A2E-B464-07D6486B81A1 Q34440014-583E3419-0A3A-4B2D-A5BF-3BB4D9A1BFA6 Q34483187-AA1FF327-B8FA-4745-888A-3944E0AF8838 Q34489436-11763429-1A17-4AD0-817F-8F98D48F1183 Q34514689-1D66808C-7039-4E9A-98AB-945BED9E4EED Q34828833-05E12856-D723-4A9A-AAC0-E0824217B7D7 Q35248255-68F1107D-0956-4195-8D12-E931853A2939 Q35383102-6163606A-D9BC-464D-8B8D-14BA29958663 Q35571271-4BD54CD3-1723-4312-9973-A89859D9AAF4 Q35581405-6EC0B331-041C-4134-9DB8-B86B1238DD85 Q35644546-92079A02-595D-47D0-B24F-0B481F4DC87F Q35668869-3373ADF1-FCD0-4FA9-A78B-0EEC5F2CC5C7 Q35831485-2AAF1F26-75E7-4A1E-98BE-CF57C3107B3E Q35937351-9E239519-FFFD-4DA5-8926-F19BEBD13A1C Q36032361-BA504EB9-8021-436F-A159-51A4F4F1BCDC Q36134690-785800F4-26FB-4A2C-BCD5-AB4840F0B4EE Q36147848-106C44AF-2813-400A-BE39-39594E25A29D Q36253022-54BC9E5F-2455-40A6-A859-640E147FB8DC Q36384759-046B7C59-B889-4468-B5C6-32DE74AFB9A0 Q36582422-46BC3D36-486E-4253-A304-FDF53CE65BDB Q37142857-262A739B-6B6A-4175-ACD5-82F3F58F0DB4 Q37142875-060F045A-AF99-4612-AD8A-E0BCA8A5C45F Q37235572-4A9AECF8-548A-4516-A767-7F4B40FBA39A Q37547409-C22A9FE1-A4A4-46E3-A774-1A4092E30252

P2860

Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation

http://www.wikidata.org/entity/Q33882805

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Smart hydrogel particles: biom ...... protection against degradation

@ast

Smart hydrogel particles: biom ...... protection against degradation

@en

type

label

Smart hydrogel particles: biom ...... protection against degradation

@ast

Smart hydrogel particles: biom ...... protection against degradation

@en

prefLabel

Smart hydrogel particles: biom ...... protection against degradation

@ast

Smart hydrogel particles: biom ...... protection against degradation

@en

P1433

Q33882805-D5F6B540-0CE1-4573-BEA3-9C0D5D36A08B

P1476

Q33882805-ADC5F343-686C-4912-AC98-AA540BDCDC26

P2093

Q33882805-05A87047-5DB0-4C62-8071-C6585D30F9E3

Q33882805-0E090200-6971-4011-AD02-7F69A25A3FB6

Q33882805-2975DC06-E334-4F67-870E-91974647D4ED

Q33882805-458C64DD-EA7F-48CC-9129-271B55D6CF64

Q33882805-5A82096D-4D9C-45B9-810E-0A2E675C8CE5

Q33882805-70FF6ABA-8A5E-48DD-8EAA-CBF08F0685F4

Q33882805-71BF9E11-DD00-4893-8BAA-224700AD4816

Q33882805-B2CA8CFF-A45D-4FBE-AAF1-027DCCD8220D

Q33882805-C20D4E3C-790F-4457-A605-64DBF7AD73F4

Q33882805-CADF43A5-7A7A-40B3-9580-B043EBA5BCDD

P2860

Q33882805-1D257DA2-8F17-4590-8369-790C56F49D75

Q33882805-2826A401-8CA2-489D-823B-B232DC987D1B

Q33882805-28DDA2EB-5ED3-4804-AFCE-D156F4A31608

Q33882805-34471C59-6A1B-4059-82D8-707972441B02

Q33882805-37DCCD22-5754-4C26-99BA-4607467B0E5A

Q33882805-45253014-CBC9-4AC2-B4EE-0329A54D0E22

Q33882805-45BEA7B6-C6E6-4A5C-AED1-0AE79381C066

Q33882805-50D0B268-B9D4-4FD2-90EF-4FD2F0206E23

Q33882805-5B4AE29E-3F21-4CBA-B054-1A457A596DEC

Q33882805-5CCACE61-FA47-4A95-B26E-5BE01A855699

P304

Q33882805-41FB7243-CB28-4A23-979A-5B8F32539A4A

P31

Q33882805-B33E5D0D-2464-4342-953E-1571AE7735BA

P356

Q33882805-CA4526E0-291F-42F2-9EA1-F98343F8EE4C

P407

Q33882805-C34D0594-4729-4CF3-8517-0C45CD3E0595

P433

Q33882805-530997CD-B370-4264-B51A-08C1F10BB6C3

P478

Q33882805-812A5FAC-691E-4BA2-9637-22E80498433B

P577

Q33882805-BC62E0A0-C0AC-4212-91D1-22CAD873C207

P5875

Q33882805-94B97243-931D-4D6A-8A47-BBE1FDE526EE

P698

Q33882805-F985886D-8128-4315-823B-FCDBD14EEB10

P921

Q33882805-71FD6AFB-049F-45B5-B9FC-47BE3B823C27

Q33882805-DD68892D-A3CB-4B89-9D9C-777F536997D0

P932

Q33882805-B2C6F3BF-B0FD-40B2-B849-42E53D4C0166

P356

P1433

P1476

Smart hydrogel particles: biom ...... protection against degradation

@en

P2093

Alessandra Luchini

http://www.w3.org/2001/XMLSchema#string

Alessandra Tessitore

http://www.w3.org/2001/XMLSchema#string

Alexis Patanarut

http://www.w3.org/2001/XMLSchema#string

Barney Bishop

http://www.w3.org/2001/XMLSchema#string

Cassandra Xia

http://www.w3.org/2001/XMLSchema#string

Clinton D Jones

http://www.w3.org/2001/XMLSchema#string

David H Geho

http://www.w3.org/2001/XMLSchema#string

Duy Tran

http://www.w3.org/2001/XMLSchema#string

Emanuel F Petricoin

http://www.w3.org/2001/XMLSchema#string

Lance A Liotta

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of albumin-associated peptides and proteins from ovarian cancer patients

The human plasma proteome: history, character, and diagnostic prospects

Characterization of the low molecular weight human serum proteome.

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.

Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.

Temperature-sensitive aqueous microgels.

Proteomics for cancer biomarker discovery.

Clinical biomarkers in drug discovery and development.

Protein microarrays: molecular profiling technologies for clinical specimens.

P304

350-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NL072174L

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5772762

http://www.w3.org/2001/XMLSchema#string

P698

18076201

http://www.w3.org/2001/XMLSchema#string

P921

P932

2877922

http://www.w3.org/2001/XMLSchema#string